These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 16281444)
21. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [TBL] [Abstract][Full Text] [Related]
30. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Jasti H; Mortensen EM; Obrosky DS; Kapoor WN; Fine MJ Clin Infect Dis; 2008 Feb; 46(4):550-6. PubMed ID: 18194099 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Li JZ; Winston LG; Moore DH; Bent S Am J Med; 2007 Sep; 120(9):783-90. PubMed ID: 17765048 [TBL] [Abstract][Full Text] [Related]
32. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated. Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA Vaccine; 2007 Jun; 25(23):4631-40. PubMed ID: 17478015 [TBL] [Abstract][Full Text] [Related]
33. Audit of the management of patients admitted with community acquired pneumonia. Foley SC; Kelly EM; O'Neill SJ Ir Med J; 2006 May; 99(5):138-40. PubMed ID: 16892917 [TBL] [Abstract][Full Text] [Related]
34. Community-acquired infectious pneumonia in puppies: 65 cases (1993-2002). Radhakrishnan A; Drobatz KJ; Culp WT; King LG J Am Vet Med Assoc; 2007 May; 230(10):1493-7. PubMed ID: 17504040 [TBL] [Abstract][Full Text] [Related]
35. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML; Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484 [TBL] [Abstract][Full Text] [Related]
36. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission. Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462 [TBL] [Abstract][Full Text] [Related]
37. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial. Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644 [TBL] [Abstract][Full Text] [Related]
38. Effect of emergency department crowding on time to antibiotics in patients admitted with community-acquired pneumonia. Fee C; Weber EJ; Maak CA; Bacchetti P Ann Emerg Med; 2007 Nov; 50(5):501-9, 509.e1. PubMed ID: 17913300 [TBL] [Abstract][Full Text] [Related]
39. Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin. Rowe BH; Campbell SG; Boudreaux ED; Colman I; Abu-Laban RB; Sivilotti ML; Clark S; Camargo CA Acad Emerg Med; 2007 Jul; 14(7):607-15. PubMed ID: 17478882 [TBL] [Abstract][Full Text] [Related]
40. Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia. Spaude KA; Abrutyn E; Kirchner C; Kim A; Daley J; Fisman DN Arch Intern Med; 2007 Jan; 167(1):53-9. PubMed ID: 17210878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]